NEWS RELEASE: Leica Biosystems Revolutionizes Histology Workflows with Global Launch of the Leica CM1950 Cryostat with DualEcoTec Cooling System
DEER PARK, IL — Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is redefining histology workflows with the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling System. This next-generation solution delivers superior performance, sustainability, and enhanced technician comfort—setting a new standard for cryostat technology.
With up to 3x faster specimen cooling and up to 2x faster chamber cooling, the system significantly reduces setup time and case duration while ensuring reliable sectioning, even during extended cutting sessions. The system accelerates workflows by providing rapid cooling for complex specimens and ultra-low temperatures to –50 °C for critical samples in surgical settings.
As the first cryostat in its class to utilize a next-generation refrigerant with near-zero global warming potential, the Leica CM1950 Cryostat with DualEcoTec Cooling System leads the way in sustainability-focused innovation. With up to 50% lower energy consumption compared to previous models, laboratories benefit from operating cost savings and reduced environmental impact—reinforcing the commitment from Leica Biosystems to sustainable solutions without compromising precision or performance.
“Laboratory needs continue to evolve, and we are committed to listening to our customers and delivering innovations that truly move the field forward,” said Naveen Chandra, Vice President and General Manager of Digital Pathology & Innovation at Leica Biosystems. “This breakthrough significantly reduces waiting times while ensuring consistent temperature control and reliable, high-quality sections—even during extended cutting sessions. The result is faster turnaround, greater confidence in results, and more efficient workflows. Beyond performance, it lowers total cost of ownership, helping laboratories operate more sustainably without compromising standards of care. We are proud to lead the advancement of technologies that empower histology professionals and improve patient outcomes.”
The Leica CM1950 Cryostat with DualEcoTec Cooling System, for in vitro diagnostic use, prioritizes technician well-being by reducing heat emission by 33% and noise levels by 50% to create a cooler, quieter, and more comfortable work environment. Combined with ergonomic design enhancements that support long sectioning sessions, these improvements help reduce fatigue, improve focus, and support technician comfort—ultimately contributing to both productivity and consistent diagnostic outcomes in busy histology labs.
For more information, click here.
For In Vitro Diagnostic Use.
About Leica Biosystems
Leica Biosystems is a cancer diagnostics company and a global leader in anatomic and digital pathology solutions. The company offers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. As the only company to own the full workflow from biopsy to diagnosis, Leica Biosystems is uniquely positioned to break down the barriers between each step. The company’s mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of its corporate culture. Leica Biosystems is proud to be a Danaher Corporation subsidiary.
About Danaher
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher’s advanced science and technology – and proven ability to innovate – help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
